ArticleOphthalmology science2026

Assessing the Safety and Efficacy of Agonistic Monoclonal Antibody against Robo4 versus Ranibizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Phase I, Open-Label, Multicenter Study.

Rubbia Afridi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.